Patent details

Basic Information

Publication number:

EP3377063

PCT Application Number:

EP2016078076

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167986983

PCT Publication Number:

WO2017085226

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA

French Title of Invention:

UTILISATION D'IVERMECTINE ET DE BRIMONIDINE DANS LE TRAITEMENT ET/OU LA PRÉVENTION DE LA ROSACÉE MODÉRÉE À GRAVE

German Title of Invention:

VERWENDUNG VON IVERMECTIN UND BRIMONIDIN ZUR BEHANDLUNG UND/ODER VORBEUGUNG VON MITTELSCHWERER BIS SCHWERER ROSAZEA

SPC Number:

Dates

Filing date:

17/11/2016

Grant date:

09/08/2023

EP Publication Date:

26/09/2018

PCT Publication Date:

26/05/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/08/2023

EP B1 Publication Date:

09/08/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/11/2023

Expiration date:

17/11/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/08/2023

 

 

Name:

Galderma S.A.

Address:

Zugerstrasse 8, 6330 Cham, Switzerland (CH)

Inventor

1

Name:

MARTEL, Philippe

Address:

France (FR)

2

Name:

AUDIBERT, Fabien

Address:

France (FR)

3

Name:

KERROUCHE, Nabil

Address:

France (FR)

Priority

Priority Number:

15306822

Priority Date:

17/11/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/498; A61K 31/7048; A61P 17/00;

Publication

European Patent Bulletin

Issue number:

202332

Publication date:

09/08/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer: